Encorafenib, binimetinib and cetuximab in BRAF V600E-mutated advanced pancreatic adenocarcinoma

ESMO Open. 2024 Nov;9(11):103975. doi: 10.1016/j.esmoop.2024.103975. Epub 2024 Oct 26.
No abstract available

Publication types

  • Letter